Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein Scios Inc, Brown University, Amgen Clinical Immunology (2007). [ISPRI prediction of immunogenicity]
- EpiVax and GAIA Vaccine Foundation Celebrate Women’s Achievements Throughout History and Across Nations
- Immune Engineering Cas9: Yes We Can!
- EpiVax Awarded Grant to Develop New Graves’ Disease Therapy
- The DIY Movement . . . in Cancer Vaccines
- Big Dog, Little Dog (Biologics) – Both Need Immunogenicity Risk Assessment